Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can online therapy shield aging brains after the ICU?

NCT ID NCT06627894

First seen Jan 11, 2026 · Last updated Jun 19, 2026 · Updated 27 times

Summary

This study tests whether an internet-based cognitive behavioral therapy program, called Good Days Ahead, can reduce depression and slow down memory and thinking problems in older adults who have been in the intensive care unit (ICU). The trial will enroll 300 people aged 50 and older who have depressive symptoms after an ICU stay. Participants will either receive the online therapy or standard depression education and monitoring, and researchers will track changes in their thinking abilities and quality of life over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Eskenazi Hospital

    RECRUITING

    Indianapolis, Indiana, 46202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • IU Health Methodist Hospital

    RECRUITING

    Indianapolis, Indiana, 46202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Internet-based cognitive behavioral therapy (Good Days Ahead)

What this could lead to

If successful, this could provide a practical, home-based treatment to improve mood and potentially slow memory and thinking problems in older adults after a serious illness.

What could go wrong

This is a relatively early-stage trial (Phase NA) testing a behavioral intervention, not a drug. The effect on cognitive decline is uncertain, and benefits may be modest or not apply to everyone.

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Depression depressive disorder subjective cognitive decline

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.